Mouth Ulcer Treatment Market - By Drug Class (Antimicrobial, Antihistamine, Analgesic, Corticosteroid), Drug Form (Sprays, Mouthwash, Gel, Lozenge), Indication (Aphthous Stomatitis, Oral Lichen Planus), Distribution Channel – Global Forecast 2024 – 2032

Mouth Ulcer Treatment Market Size

Mouth ulcer treatment market size was valued at around USD 1.5 billion in 2023 and is estimated to grow at 4% CAGR from 2024 to 2032. Mouth ulcers, also known as canker sores, are small, painful lesions that develop in the mouth or at the base of the gums. They can make eating, drinking, and talking uncomfortable. Mouth ulcers are usually round or oval with a white or yellow center and a red border. While most mouth ulcers are harmless and resolve on their own, they can be quite painful and disruptive.
 

The rising incidence of mouth ulcers is a significant driver for the market. For instance, according to the National Center for Biotechnology Information (NCBI) in 2023, recurrent aphthous ulcer (RAU), also known as recurrent aphthous stomatitis or more commonly mouth ulcers, affects approximately 25% of the global population. Therefore, this underscores the increasing demand for innovative and effective treatments in the mouth ulcer treatment market. Furthermore, increasing awareness and diagnosis and advancements in treatment options, are driving factors for the market growth.
 

Mouth Ulcer Treatment Market Trends

Advancements in the treatment of mouth ulcers have significantly improved options for managing and alleviating symptoms. From traditional topical treatments that provide pain relief and promote healing to emerging therapies such as laser therapy and biologic agents, there are now more effective strategies tailored to address the varying severity and underlying causes of this common oral condition. These advancements reflect a growing understanding of ulcer pathophysiology and a commitment to enhancing patient comfort and outcomes in oral healthcare.
 

• Advanced topical steroids such as triamcinolone acetonide dental paste, have shown effectiveness in reducing inflammation and accelerating healing of mouth ulcers. These steroids may be prescribed in cases of severe or recurrent ulcers.
   
• Emerging treatments include the use of biological agents such as monoclonal antibodies, which is estimated to reach USD 609 billion by 2032, targeting specific immune pathways implicated in oral ulceration disorders, offering potential targeted therapy for more severe or refractory cases.
   
• Additionally, mouthwashes or topical applications containing antimicrobial agents like chlorhexidine can help reduce the risk of secondary infections in mouth ulcers, promoting faster healing. Thus, propelling the growth of the market.
   

Mouth Ulcer Treatment Market Analysis

Based on drug class, the market is divided into antimicrobial, antihistamine, analgesics & corticosteroids, and other drug classes. The antimicrobial segment of the market is forecasted to reach USD 693.4 million by 2032.
 

• Antimicrobial agents help reduce the risk of secondary bacterial infections in mouth ulcers, which can exacerbate symptoms and delay healing. By targeting and eliminating harmful bacteria, these agents create a more favorable environment for ulcer resolution.
   
• By controlling bacterial growth and inflammation at the ulcer site, antimicrobial agents facilitate faster healing of mouth ulcers. This accelerates the resolution of symptoms such as pain and discomfort associated with the ulcers.
   
• Further, effective antimicrobial treatment can prevent complications such as abscess formation or the spread of infection to surrounding tissues. This is particularly important in individuals with compromised immune systems or systemic conditions predisposing them to oral infections, thus driving the market growth.

Based on drug form, the mouth ulcer treatment market is bifurcated into sprays, mouthwash, gels, and lozenges. The gels segment accounted for USD 622.8 million in 2023.
 

• Mouth ulcer gels often contain local anesthetics such as benzocaine or lidocaine, which provide immediate pain relief by numbing the ulcerated area. This helps alleviate discomfort during eating, speaking, and oral hygiene practices.
   
• Gels form a protective barrier over the ulcer, shielding it from further irritation caused by food, beverages, and oral bacteria. This barrier promotes healing by allowing the ulcerated tissue to regenerate without additional trauma.
   
• Certain gels contain anti-inflammatory drugs such as corticosteroids, that reduce inflammation and swelling associated with mouth ulcers. This helps to alleviate pain and accelerate healing. Thus, propelling the growth of the market.
   

Based on indication, the mouth ulcer treatment market is divided into aphthous stomatitis, oral lichen planus, oral candidiasis, and other indications. The aphthous stomatitis segment of the market is forecasted to reach USD 1.1 billion by 2032.
 

• Treatment options such as topical analgesics provide immediate relief from pain and discomfort associated with aphthous stomatitis. This allows patients to eat, drink, and speak more comfortably.
   
• Topical treatments such as corticosteroid gels or pastes help reduce inflammation and promote faster healing of aphthous ulcers. This accelerates the resolution of symptoms and shortens the duration of ulcer episodes.
   
• Effective management of aphthous stomatitis helps prevent complications such as secondary infections or the development of larger, more painful ulcers. This is particularly important in individuals with compromised immune systems or systemic conditions. Thus, escalating the growth of the market.
   

Based on distribution channel, the mouth ulcer treatment market is bifurcated into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment accounted for USD 571.1 million in 2023.
 

• Hospital pharmacies ensure timely availability of medications and topical treatments for mouth ulcers, allowing healthcare providers to initiate treatment promptly upon diagnosis.
   
• Hospital pharmacies collaborate closely with healthcare teams, including dentists, oral surgeons, and specialists in oral medicine, to coordinate treatment plans for patients with severe or recurrent mouth ulcers. This interdisciplinary approach ensures comprehensive care and improved patient outcomes.
   
• Hospital pharmacies adhere to strict quality assurance standards and regulatory requirements for medication storage, preparation, and dispensing. This ensures the safety and reliability of medications used in mouth ulcer treatment, promoting patient confidence and trust, thus driving demand in this segment.

The growth of the mouth ulcer treatment market in the U.S. projected to reach USD 809.4 million by 2032.
 

• The U.S. boasts a highly developed healthcare system with widespread access to medical facilities, including hospitals, clinics, and specialized dental practices. This infrastructure supports comprehensive diagnosis, treatment, and management of mouth ulcers.
   
• The U.S. leads in medical research and innovation, including advancements in oral health. Academic institutions and private companies conduct cutting-edge research into the pathophysiology of mouth ulcers and the development of new treatment modalities.
   

The mouth ulcer treatment market in UK is expected to experience significant and promising growth from 2024 to 2032.
 

• The UK's National Health Service (NHS) provides universal healthcare coverage, ensuring access to medical services, including oral health care, for all residents. This comprehensive system supports early diagnosis and effective treatment of mouth ulcers across the population.
   

Japan market is anticipated to witness lucrative growth between 2024 – 2032.
 

• Japan is renowned for its leadership in technological innovation, including medical devices and pharmaceuticals. This innovation extends to the development of advanced treatments and therapies for oral health conditions, including mouth ulcers.
   
• Japan boasts a robust pharmaceutical industry with companies specializing in oral healthcare products. These companies develop and manufacture a variety of medications, topical treatments, and oral care products tailored for treating mouth ulcers.
   

The mouth ulcer treatment market in Saudi Arabia is expected to experience significant and promising growth from 2024 to 2032.
 

• Saudi Arabia has access to state-of-the-art medical technologies and equipment, including diagnostic tools and treatment modalities for oral conditions. This access enhances the capability to diagnose and treat mouth ulcers effectively.
   
• Saudi Arabia has been heavily investing in its healthcare infrastructure, including hospitals, clinics, and specialized healthcare centers. This investment supports the availability of advanced diagnostic and treatment facilities for managing mouth ulcers.
   

Mouth Ulcer Treatment Market Share

The mouth ulcer treatment sector is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A pivotal aspect of market strategy involves the continual introduction of innovative products leveraging diverse technologies. Notably, prominent industry players command considerable influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding global footprint amidst evolving regulatory landscapes.
 

Mouth Ulcer Treatment Market Companies

Some of the eminent market participants operating in the mouth ulcer treatment industry include:

• 3M Company
• Blistex Inc.   
• Bristol Myers Squibb Company      
• Church & Dwight Co., Inc.  
• Colgate- Palmolive Company         
• Dental Herb Company        
• DR. Reddy’s Laboratories Limited   
• Forward Science      
• GSK plc        
• Johnson & Johnson
• Patterson Companies, Inc.
• Prestige Consumer Healthcare Inc.
• Pfizer, Inc.    
• Prince Care Pharma Pvt Ltd 
• Taro Pharmaceutical Industries Ltd.
   

Mouth Ulcer Treatment Industry News

• In December 2021, Forward Science released BioStom, a nonopioid oral pain-relief gel. The gel was designed to manage pain associated with oral wounds, mouth sores, injuries, and mucosal ulcers. This product innovation benefited Forward Science by expanding its portfolio to include a nonopioid pain relief option, addressing a critical need for effective oral pain management while aligning with growing healthcare trends towards opioid-free treatments.
   

The mouth ulcer treatment market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Drug Class

• Antimicrobial
• Antihistamine
• Analgesics & corticosteroids
• Other drug classes

Market, By Drug Form

• Sprays
• Mouthwash
• Gels
• Lozenges

Market, By Indication

• Aphthous stomatitis
• Oral lichen planus
• Oral candidiasis
• Other indications

Market, By Distribution Channel

• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America 
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa